Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations – Nature Immunology

Krebs and colleagues identify multiple mAbs that recognize either the RBD or the NTD of SARS-CoV-2 spike protein that have potent cross-neutralizing activities against variants of concern. Combinatorial mAb cocktails have complementary effects on viral neutralization and Fc effector functions and can protect against SARS-CoV-2 escape mutants.

Read the full article here

Related Articles